TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35692074

Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-controlled trial (AIR2)
Number of subjects: 0
Study: 33118432

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional Balloon (Control)
Number of subjects: 120
Study: 32274653

Group type: COMPARATOR
Intervention: Peficitinib (20, 60, or 200 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Peficitinib (10, 30, or 100 mg) twice daily for 7 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 35255229

Group type: EXPERIMENTAL
Intervention: 5 mg/day empagliflozin (EMPA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No drug (NOEMPA)
Number of subjects: 39
Study: 33343503

Group type: EXPERIMENTAL
Intervention: Updating training (N-back type exercises)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Inhibition training (Stroop-like exercises)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Active control (general knowledge quiz game)
Number of subjects: 90
Study: 34275586

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg/day) and Temozolomide (50 mg/m2/day)
Number of subjects: 18
Study: 33375932

Group type: EXPERIMENTAL
Intervention: Modulation of host thromboinflammatory response
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 35199237

Group type: EXPERIMENTAL
Intervention: Intra-dialysis exercise program (n = 36)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (n = 35)
Number of subjects: 71
Study: 33515019

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 508

Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 508
Study: 32087182

Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 50
Study: 35405469

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Recurrent UTI
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Genitourinary abnormalities
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: TMP-SMX use within 90 days
Number of subjects: 427

Group type: COMPARATOR
Intervention: ED population
Number of subjects: 427
Study: 33626144

Group type: EXPERIMENTAL
Intervention: Foam Rolling Group (FRG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study: 32693177

Group type: EXPERIMENTAL
Intervention: PiHQ (Partners in Helping You Quit) program
Number of subjects: 106

Group type: COMPARATOR
Intervention: QL (Massachusetts Quitline) program
Number of subjects: 106
Study: 34487566

Group type: EXPERIMENTAL
Intervention: Low-energy CO2 laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 34246887

Group type: EXPERIMENTAL
Intervention: Intense physical exercise (cycling at 80% of maximum heart rate) prior to exposures
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intense physical exercise prior to exposures (control group)
Number of subjects: 60
Study: 34427492

Group type: EXPERIMENTAL
Intervention: Vocational interventions focusing on interpersonal functioning, emptiness, and identity disturbance.
Number of subjects: 112

Group type: COMPARATOR
Intervention: Not applicable (control group not specified).
Number of subjects: 112
Study: 34653287

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) - two 15 mg/kg infusions 7 days apart; maximum dose, 750 mg single/1500 mg total
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 35085264

Group type: EXPERIMENTAL
Intervention: Community beliefs and attitudes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations of community beliefs and attitudes
Number of subjects: 0
Study: 32771321

Group type: EXPERIMENTAL
Intervention: Removal of both oxygen sources
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Removal of non–rebreather mask with nasal cannula left in place
Number of subjects: 42
Study: 35708895

Group type: EXPERIMENTAL
Intervention: Nomogram based on cumulative anthracycline dose, ejection fractions, NT-proBNP, and diastolic dysfunction.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Nomogram evaluation using Hosmer-Lemeshow test.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Nomogram clinical utility assessed by decision curve analysis (DCA).
Number of subjects: 796
Study: 35582891

Group type: EXPERIMENTAL
Intervention: Provider education regarding blood glucose flowsheet orders
Number of subjects: 7052

Group type: EXPERIMENTAL
Intervention: Reminder interventions emphasizing accountability to the provider
Number of subjects: 7052

Group type: EXPERIMENTAL
Intervention: Provider education and reminder interventions
Number of subjects: 7052
Study: 32737585

Group type: EXPERIMENTAL
Intervention: 7.5% CO2 inhalation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Medical air (placebo) inhalation
Number of subjects: 22
Study: 32774636

Group type: EXPERIMENTAL
Intervention: Street children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Private secondary school students (PSSS)
Number of subjects: 0
Study: 35020572

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief hypnosis intervention via audio recording
Number of subjects: 0
Study: 34915981

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 34787005

Group type: EXPERIMENTAL
Intervention: Ofatumumab 20 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34847676

Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS) daily for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous tibial nerve stimulation (PTNS) weekly for 3 months
Number of subjects: 60
Study: 34396816

Group type: EXPERIMENTAL
Intervention: Topical application of 100% lavender essential oil
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Inhaler application of 100% lavender essential oil
Number of subjects: 90

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 90
Study: 33359435

Group type: EXPERIMENTAL
Intervention: Endoscopic radiofrequency ablation (RFA) plus plastic stent placement
Number of subjects: 174

Group type: COMPARATOR
Intervention: Plastic stent placement alone
Number of subjects: 174
Study: 32820861

Group type: EXPERIMENTAL
Intervention: Proposed biosimilar filgrastim
Number of subjects: 23

Group type: COMPARATOR
Intervention: Innovator filgrastim
Number of subjects: 23
Study: 32408022

Group type: EXPERIMENTAL
Intervention: Caregiver Support Intervention (CSI)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 78
Study: 34125899

Group type: EXPERIMENTAL
Intervention: Standard-dose VitD/Ca supplementation (400 IU/1200 mg/day) for 48 weeks
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High-dose VitD/Ca supplementation (400 IU/1200 mg/day plus ergocalciferol 20,000 IU/week) for 48 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Both treatment groups (Standard-dose and High-dose)
Number of subjects: 200
Study: 33239945

Group type: EXPERIMENTAL
Intervention: Warm-up at 80% VO2 max
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Warm-up at 60% VO2 max
Number of subjects: 9

Group type: COMPARATOR
Intervention: No warm-up (control)
Number of subjects: 9
Study: 35751898

Group type: EXPERIMENTAL
Intervention: Bushen-Shugan (BSSG) method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32991477

Group type: EXPERIMENTAL
Intervention: Visual feedback balance training with the Pro-kin system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pro-kin system parameters (perimeter and ellipse area)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Timed 'Up & Go' (TUG) test
Number of subjects: 40
Study: 34389753

Group type: EXPERIMENTAL
Intervention: Orgono Powder (silicon as orthosilicic acid with maltodextrin)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: G5 Siliplant (silicon as orthosilicic acid with Equisetum arvense and Rosmarinus officinalis)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: G7 Aloe (silicon as orthosilicic acid with aloe vera)
Number of subjects: 5
Study: 32026829

Group type: COMPARATOR
Intervention: Usual care: one usual physiotherapy advice and assessment session, including setting a physical activity goal and one follow up session (8 weeks).
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: "Walk30×5": session one, usual care plus intervention of walking programme. Participants were shown the website and podcasts and practiced how to use them. One follow up session (8 weeks).
Number of subjects: 41
Study: 36190944

Group type: EXPERIMENTAL
Intervention: Risk modification (RM)
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Exposure modification (EM)
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1557
Study: 33624240

Group type: EXPERIMENTAL
Intervention: Anaerobically digested swine manure at 25 g·kg‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Anaerobically digested swine manure at 10 g·kg‐1
Number of subjects: 3

Group type: COMPARATOR
Intervention: Anaerobically digested swine manure at 0 g·kg‐1
Number of subjects: 3
Study: 32338001

Group type: EXPERIMENTAL
Intervention: Deep-fried potato products (potato chips and French fries)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boiled potatoes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boiled rice
Number of subjects: 0
Study: 34108431

Group type: EXPERIMENTAL
Intervention: Pregabalin (n = 10)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 24
Study: 34859788

Group type: EXPERIMENTAL
Intervention: 400 mg Mg as Mg citrate daily for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo daily for 12 weeks
Number of subjects: 24
Study: 33254007

Group type: EXPERIMENTAL
Intervention: Fitness training
Number of subjects: 110
Study: 33160891

Group type: EXPERIMENTAL
Intervention: LVGFI
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Infarct size
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Conicity index
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Sphericity index
Number of subjects: 129
Study: 36247849

Group type: EXPERIMENTAL
Intervention: Acupuncture for tonifying kidney and removing blood stasis combined with radiofrequency surgery
Number of subjects: 122

Group type: COMPARATOR
Intervention: CT-guided percutaneous radiofrequency ablation therapy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combined detection of NTx, BGP, and CYFRA21-1
Number of subjects: 122
Study: 32621106

Group type: EXPERIMENTAL
Intervention: ICCRTC classification system
Number of subjects: 60
Study: 35241351

Group type: EXPERIMENTAL
Intervention: Nicotine patch adherence
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Withdrawal symptoms
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Severity of withdrawal symptoms
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Quit day smoking status, patch adherence, duration of abstinence, and percent negative CO samples submitted
Number of subjects: 70
Study: 36190380

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg per day for 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 30
Study: 34291808

Group type: EXPERIMENTAL
Intervention: Digital Cognitive Behavioral Therapy for Insomnia (dCBT‐I)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Face-to-face Cognitive Behavioral Therapy for Insomnia (FtF CBT‐I)
Number of subjects: 101
Study: 32807435

Group type: EXPERIMENTAL
Intervention: Informational support provided individually and in groups from the third to the eleventh day of hospitalization
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 78
Study: 35473459

Group type: EXPERIMENTAL
Intervention: Jcerity Endoscoper Airway (JEA)
Number of subjects: 182

Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 182
Study: 34972091

Group type: EXPERIMENTAL
Intervention: 24-hour passive subdural drainage
Number of subjects: 420

Group type: COMPARATOR
Intervention: 48-hour passive subdural drainage
Number of subjects: 420
Study: 34193328

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Therapy for Insomnia (MBTI)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Sleep Hygiene, Education, and Exercise Program (SHEEP)
Number of subjects: 127
Study: 33678399

Group type: EXPERIMENTAL
Intervention: 21-day Brush Day & Night programme
Number of subjects: 4125

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4125
Study: 32500957

Group type: EXPERIMENTAL
Intervention: Extended hours dialysis (median 24 h/wk)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard hours dialysis (median 12 h/wk)
Number of subjects: 200
Study: 33882590

Group type: EXPERIMENTAL
Intervention: 80 mg of aspirin
Number of subjects: 50
Study: 35138715

Group type: EXPERIMENTAL
Intervention: Hospital-at-home (HaH) care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospitalization
Number of subjects: 0
Study: 32343001

Group type: EXPERIMENTAL
Intervention: Gaviscon Advance
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-alginate antacid
Number of subjects: 26
Study: 35195339

Group type: EXPERIMENTAL
Intervention: RT + HMB
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: RT
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: HMB
Number of subjects: 200

Group type: COMPARATOR
Intervention: Negative Control
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 200
Study: 34428500

Group type: EXPERIMENTAL
Intervention: Direct evidence from Randomized Controlled Trials (RCTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative approaches (non-randomized studies or RCTs on indirect populations)
Number of subjects: 0
Study: 34326132

Group type: EXPERIMENTAL
Intervention: Lenvatinib 24 mg/day
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 36304748

Group type: EXPERIMENTAL
Intervention: Prediction model for CVDs in COPD patients based on predictors including gender, age, smoking history, BMI, history of blood transfusion, history of heart disease in close relatives, WBC, MONO, PLT, and LYM.
Number of subjects: 1022
Study: 34921515

Group type: EXPERIMENTAL
Intervention: Tracer contact
Number of subjects: 4380
Study: 35659713

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.2% (50 cc) sprayed through the laparoscopic port
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intra-abdominal bicarbonate (5.7% dissolved in 1000 cc normal saline)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normal saline abdominal lavage
Number of subjects: 58
Study: 33577055

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg twice daily for 12 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 32147280

Group type: EXPERIMENTAL
Intervention: Digital aspiration
Number of subjects: 67

Group type: COMPARATOR
Intervention: Manual aspiration
Number of subjects: 67
Study: 36113275

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) combined with core stability-based balance training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Core stability-based balance training (Control group)
Number of subjects: 30
Study: 34408055

Group type: EXPERIMENTAL
Intervention: Solution-focused brief therapy, up to six sessions over 3 months, offered immediately postrandomisation or after a delay of 6 months.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wait-list control group (delayed intervention).
Number of subjects: 32
Study: 35507735

Group type: EXPERIMENTAL
Intervention: Dual-zone therapeutic concept (DZ)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bone grafting to buccal bone crest (BCG)
Number of subjects: 24
Study: 34505720

Group type: EXPERIMENTAL
Intervention: Income quartiles (highest income quartile)
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: Income quartiles (lowest income quartile)
Number of subjects: 2006

Group type: COMPARATOR
Intervention: Income quartiles (all quartiles)
Number of subjects: 2006
Study: 33153273

Group type: EXPERIMENTAL
Intervention: Financial hardship treatment adherence
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Financial stress
Number of subjects: 68
Study: 33407146

Group type: EXPERIMENTAL
Intervention: Noninvasive predictive model using AST, anti-HBC, and GGT
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Liver biopsy showing moderate or severe inflammation or significant fibrosis
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Independent predictors for antiviral therapy
Number of subjects: 577
Study: 36007538

Group type: EXPERIMENTAL
Intervention: Luspatercept
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 34340839

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard multimodal analgesic regimen
Number of subjects: 82
Study: 34709929

Group type: EXPERIMENTAL
Intervention: Venetoclax and obinutuzumab (Ven-Obi)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Chlorambucil and obinutuzumab (Clb-Obi)
Number of subjects: 432
Study: 32580980

Group type: EXPERIMENTAL
Intervention: Comprehensive care protocol with structured individual visits (5 visits) with primary care nurse over 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diabetes care (comparison group)
Number of subjects: 0
Study: 36098290

Group type: EXPERIMENTAL
Intervention: Recreational choir singing (RCS)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Group music therapy (GMT)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 318
Study: 34735165

Group type: EXPERIMENTAL
Intervention: Reciprocity strategy (delivery of inspirational quote prior to self-reporting)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Nonmonetary reinforcers (e.g., delivery of meme/gif following self-reporting completion)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Daily self-reporting rates
Number of subjects: 68
Study: 34363766

Group type: EXPERIMENTAL
Intervention: SafeCare programme (full package)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 237
Study: 32680754

Group type: EXPERIMENTAL
Intervention: ACB combined with iPACK block and LFCNB (Group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ACB combined with iPACK block (Group B)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ACB combined with LFCNB (Group C)
Number of subjects: 200

Group type: COMPARATOR
Intervention: ACB only (Group D)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 200
Study: 36370991

Group type: COMPARATOR
Intervention: Psychological Intervention (PI) 2 times a week by a professional psychologist
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combination of Psychological Intervention (PI) and Electroacupuncture (EA) 30 min, 5 times a week for 4 weeks, total of 12 weeks
Number of subjects: 49
Study: 35668502

Group type: EXPERIMENTAL
Intervention: Living with Loss (LWL) program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 150
Study: 32510111

Group type: EXPERIMENTAL
Intervention: Intervention group (health risk assessment and nutrition counselling)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intervention group vs Control group
Number of subjects: 200
Study: 34438002

Group type: EXPERIMENTAL
Intervention: Back rubs
Number of subjects: 186

Group type: COMPARATOR
Intervention: Foot flicks
Number of subjects: 186
Study: 35135601

Group type: EXPERIMENTAL
Intervention: Theraflu Daytime Severe Cold and Cough powder for oral solution
Number of subjects: 28

Group type: COMPARATOR
Intervention: Theraflu ExpressMax Daytime Severe Cold and Cough caplet
Number of subjects: 28
Study: 35816835

Group type: EXPERIMENTAL
Intervention: Information sharing between mental health service providers and criminal legal system stakeholders
Number of subjects: 35
Study: 34591567

Group type: EXPERIMENTAL
Intervention: Promoting First Relationships (PFR) program
Number of subjects: 252

Group type: COMPARATOR
Intervention: Resource packet (control condition)
Number of subjects: 252
Study: 32791893

Group type: EXPERIMENTAL
Intervention: Confiding in others
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Television watching time
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Daytime napping
Number of subjects: 100000
Study: 616463935

Group type: EXPERIMENTAL
Intervention: IDegLira in DUAL I
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: IDegLira in DUAL IV
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: IDegLira in DUAL II
Number of subjects: 379

Group type: COMPARATOR
Intervention: Insulin degludec in DUAL I
Number of subjects: 379

Group type: COMPARATOR
Intervention: Liraglutide in DUAL I
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo in DUAL IV
Number of subjects: 379

Group type: COMPARATOR
Intervention: Insulin degludec in DUAL II
Number of subjects: 379
Study: 36316867

Group type: EXPERIMENTAL
Intervention: Orthopedic device (LSM-01)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham device (control)
Number of subjects: 30
Study: 33080085

Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 35215453

Group type: EXPERIMENTAL
Intervention: ß‐glucan prebiotic
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 33187850

Group type: EXPERIMENTAL
Intervention: Bisphenol A (BPA) exposure in groups B-D
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group A (no BPA exposure)
Number of subjects: 80
Study: 32145129

Group type: EXPERIMENTAL
Intervention: Obeticholic acid 5-10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obeticholic acid 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36479955

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy following CBT
Number of subjects: 139

Group type: COMPARATOR
Intervention: No pharmacotherapy following CBT
Number of subjects: 139